位置:首页 > 蛋白库 > RBX2_HUMAN
RBX2_HUMAN
ID   RBX2_HUMAN              Reviewed;         113 AA.
AC   Q9UBF6; A8K1H9; A8MTB5; C9JYL3; D3DNF7; D3DNF8; Q9BXN8; Q9Y5M7;
DT   03-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   03-AUG-2022, entry version 180.
DE   RecName: Full=RING-box protein 2;
DE            Short=Rbx2;
DE   AltName: Full=CKII beta-binding protein 1;
DE            Short=CKBBP1;
DE   AltName: Full=RING finger protein 7;
DE   AltName: Full=Regulator of cullins 2;
DE   AltName: Full=Sensitive to apoptosis gene protein;
GN   Name=RNF7; Synonyms=RBX2, ROC2, SAG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=10512750; DOI=10.1006/bbrc.1999.1460;
RA   Son M.-Y., Park J.-W., Kim Y.-S., Kang S.-W., Marshak D.R., Park W.,
RA   Bae Y.-S.;
RT   "Protein kinase CKII interacts with and phosphorylates the SAG protein
RT   containing ring-H2 finger motif.";
RL   Biochem. Biophys. Res. Commun. 263:743-748(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH CULLINS.
RX   PubMed=10230407; DOI=10.1016/s1097-2765(00)80482-7;
RA   Ohta T., Michel J.J., Schottelius A.J., Xiong Y.;
RT   "ROC1, a homolog of APC11, represents a family of cullin partners with an
RT   associated ubiquitin ligase activity.";
RL   Mol. Cell 3:535-541(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=10082581; DOI=10.1128/mcb.19.4.3145;
RA   Duan H., Wang Y., Aviram M., Swaroop M., Loo J.A., Bian J., Tian Y.,
RA   Mueller T., Bisgaier C.L., Sun Y.;
RT   "SAG, a novel zinc RING finger protein that protects cells from apoptosis
RT   induced by redox agents.";
RL   Mol. Cell. Biol. 19:3145-3155(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=11506706; DOI=10.1089/104454901750361488;
RA   Swaroop M., Gosink M., Sun Y.;
RT   "SAG/ROC2/Rbx2/Hrt2, a component of SCF E3 ubiquitin ligase: genomic
RT   structure, a splicing variant, and two family pseudogenes.";
RL   DNA Cell Biol. 20:425-434(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Corpus callosum, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   INTERACTION WITH CUL1, AND FUNCTION.
RX   PubMed=10851089; DOI=10.1038/sj.onc.1203635;
RA   Swaroop M., Wang Y., Miller P., Duan H., Jatkoe T., Madore S.J., Sun Y.;
RT   "Yeast homolog of human SAG/ROC2/Rbx2/Hrt2 is essential for cell growth,
RT   but not for germination: chip profiling implicates its role in cell cycle
RT   regulation.";
RL   Oncogene 19:2855-2866(2000).
RN   [11]
RP   PHOSPHORYLATION AT THR-10 BY CK2.
RX   PubMed=12748192; DOI=10.1074/jbc.m302584200;
RA   Kim Y.-S., Lee J.-Y., Son M.-Y., Park W., Bae Y.-S.;
RT   "Phosphorylation of threonine 10 on CKBBP1/SAG/ROC2/Rbx2 by protein kinase
RT   CKII promotes the degradation of IkappaBalpha and p27Kip1.";
RL   J. Biol. Chem. 278:28462-28469(2003).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   INTERACTION WITH UBE2F.
RX   PubMed=19250909; DOI=10.1016/j.molcel.2009.01.011;
RA   Huang D.T., Ayrault O., Hunt H.W., Taherbhoy A.M., Duda D.M., Scott D.C.,
RA   Borg L.A., Neale G., Murray P.J., Roussel M.F., Schulman B.A.;
RT   "E2-RING expansion of the NEDD8 cascade confers specificity to cullin
RT   modification.";
RL   Mol. Cell 33:483-495(2009).
RN   [14]
RP   INTERACTION WITH DCUN1D1; DCUN1D2; DCUN1D3; DCUN1D4 AND DCUN1D5.
RX   PubMed=26906416; DOI=10.1242/jcs.181784;
RA   Keuss M.J., Thomas Y., Mcarthur R., Wood N.T., Knebel A., Kurz T.;
RT   "Characterization of the mammalian family of DCN-type NEDD8 E3 ligases.";
RL   J. Cell Sci. 129:1441-1454(2016).
RN   [15]
RP   STRUCTURE BY NMR OF 40-113.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the RING domain of the human RING-box protein 2.";
RL   Submitted (AUG-2007) to the PDB data bank.
CC   -!- FUNCTION: Probable component of the SCF (SKP1-CUL1-F-box protein) E3
CC       ubiquitin ligase complex which mediates the ubiquitination and
CC       subsequent proteasomal degradation of target proteins involved in cell
CC       cycle progression, signal transduction and transcription
CC       (PubMed:10851089). CRLs complexes and ARIH1 collaborate in tandem to
CC       mediate ubiquitination of target proteins, ARIH1 mediating addition of
CC       the first ubiquitin on CRLs targets (By similarity). Through the RING-
CC       type zinc finger, seems to recruit the E2 ubiquitination enzyme to the
CC       complex and brings it into close proximity to the substrate. Promotes
CC       the neddylation of CUL5 via its interaction with UBE2F. May play a role
CC       in protecting cells from apoptosis induced by redox agents.
CC       {ECO:0000250|UniProtKB:P62877, ECO:0000269|PubMed:10851089}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Probable part of SCF complexes, which consist of SKP1, CUL1,
CC       RNF7/RBX2 and a F-box protein. Interacts (preferentially) with CUL5.
CC       Also interacts (with lower preference) with CUL1, CUL2, CUL3, CUL4A and
CC       CUL4B. Interacts with UBE2F. Interacts with CSNK2B, the interaction is
CC       not affected by phosphorylation by CK2. May also interact with DCUN1D1,
CC       DCUN1D2, DCUN1D3, DCUN1D4 and DCUN1D5 (PubMed:26906416).
CC       {ECO:0000269|PubMed:10230407, ECO:0000269|PubMed:10851089,
CC       ECO:0000269|PubMed:19250909, ECO:0000269|PubMed:26906416}.
CC   -!- INTERACTION:
CC       Q9UBF6; Q93034: CUL5; NbExp=8; IntAct=EBI-398632, EBI-1057139;
CC       Q9UBF6; Q9Y6K9: IKBKG; NbExp=3; IntAct=EBI-398632, EBI-81279;
CC       Q9UBF6; P12004: PCNA; NbExp=3; IntAct=EBI-398632, EBI-358311;
CC       Q9UBF6; P12504: vif; Xeno; NbExp=4; IntAct=EBI-398632, EBI-779991;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10082581}. Nucleus
CC       {ECO:0000269|PubMed:10082581}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9UBF6-1; Sequence=Displayed;
CC       Name=2; Synonyms=SAG-v;
CC         IsoId=Q9UBF6-2; Sequence=VSP_008449;
CC       Name=3;
CC         IsoId=Q9UBF6-3; Sequence=VSP_041444;
CC       Name=4;
CC         IsoId=Q9UBF6-4; Sequence=VSP_044525;
CC   -!- TISSUE SPECIFICITY: Expressed in heart, liver, skeletal muscle and
CC       pancreas. At very low levels expressed in brain, placenta and lung.
CC       {ECO:0000269|PubMed:10512750}.
CC   -!- INDUCTION: By 1,10-phenanthroline. {ECO:0000269|PubMed:10082581}.
CC   -!- DOMAIN: The RING-type zinc finger domain is essential for ubiquitin
CC       ligase activity. It coordinates an additional third zinc ion.
CC   -!- PTM: Phosphorylation by CK2 is required for efficient degradation of
CC       NFKBIA and CDKN1B. {ECO:0000269|PubMed:12748192}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Inactive. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the RING-box family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/RNF7ID44108ch3q22.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF164679; AAD55984.1; -; mRNA.
DR   EMBL; AF142060; AAD30147.1; -; mRNA.
DR   EMBL; AF092878; AAD25962.1; -; mRNA.
DR   EMBL; AF312226; AAK37450.1; -; mRNA.
DR   EMBL; BT007348; AAP36012.1; -; mRNA.
DR   EMBL; AK289894; BAF82583.1; -; mRNA.
DR   EMBL; DB272382; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC112771; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78991.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78992.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78994.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78995.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78996.1; -; Genomic_DNA.
DR   EMBL; BC005966; AAH05966.1; -; mRNA.
DR   EMBL; BC008627; AAH08627.1; -; mRNA.
DR   CCDS; CCDS3118.1; -. [Q9UBF6-1]
DR   CCDS; CCDS43158.1; -. [Q9UBF6-3]
DR   CCDS; CCDS56283.1; -. [Q9UBF6-4]
DR   RefSeq; NP_001188299.1; NM_001201370.1. [Q9UBF6-4]
DR   RefSeq; NP_055060.1; NM_014245.4. [Q9UBF6-1]
DR   RefSeq; NP_899060.1; NM_183237.2. [Q9UBF6-3]
DR   PDB; 2ECL; NMR; -; A=40-113.
DR   PDB; 7ONI; EM; 3.40 A; R=5-113.
DR   PDBsum; 2ECL; -.
DR   PDBsum; 7ONI; -.
DR   AlphaFoldDB; Q9UBF6; -.
DR   BMRB; Q9UBF6; -.
DR   SMR; Q9UBF6; -.
DR   BioGRID; 114977; 121.
DR   CORUM; Q9UBF6; -.
DR   IntAct; Q9UBF6; 30.
DR   MINT; Q9UBF6; -.
DR   STRING; 9606.ENSP00000273480; -.
DR   GlyGen; Q9UBF6; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UBF6; -.
DR   MetOSite; Q9UBF6; -.
DR   PhosphoSitePlus; Q9UBF6; -.
DR   BioMuta; RNF7; -.
DR   DMDM; 37538003; -.
DR   EPD; Q9UBF6; -.
DR   jPOST; Q9UBF6; -.
DR   MassIVE; Q9UBF6; -.
DR   MaxQB; Q9UBF6; -.
DR   PaxDb; Q9UBF6; -.
DR   PeptideAtlas; Q9UBF6; -.
DR   PRIDE; Q9UBF6; -.
DR   ProteomicsDB; 12270; -.
DR   ProteomicsDB; 83956; -. [Q9UBF6-1]
DR   ProteomicsDB; 83957; -. [Q9UBF6-2]
DR   ProteomicsDB; 83958; -. [Q9UBF6-3]
DR   Antibodypedia; 18025; 193 antibodies from 32 providers.
DR   DNASU; 9616; -.
DR   Ensembl; ENST00000273480.4; ENSP00000273480.3; ENSG00000114125.14. [Q9UBF6-1]
DR   Ensembl; ENST00000393000.3; ENSP00000376725.3; ENSG00000114125.14. [Q9UBF6-3]
DR   Ensembl; ENST00000477012.5; ENSP00000419339.1; ENSG00000114125.14. [Q9UBF6-2]
DR   Ensembl; ENST00000480908.1; ENSP00000419084.1; ENSG00000114125.14. [Q9UBF6-4]
DR   GeneID; 9616; -.
DR   KEGG; hsa:9616; -.
DR   MANE-Select; ENST00000273480.4; ENSP00000273480.3; NM_014245.5; NP_055060.1.
DR   UCSC; uc003euc.4; human. [Q9UBF6-1]
DR   CTD; 9616; -.
DR   DisGeNET; 9616; -.
DR   GeneCards; RNF7; -.
DR   HGNC; HGNC:10070; RNF7.
DR   HPA; ENSG00000114125; Low tissue specificity.
DR   MIM; 603863; gene.
DR   neXtProt; NX_Q9UBF6; -.
DR   OpenTargets; ENSG00000114125; -.
DR   PharmGKB; PA34444; -.
DR   VEuPathDB; HostDB:ENSG00000114125; -.
DR   eggNOG; KOG2930; Eukaryota.
DR   GeneTree; ENSGT00940000155481; -.
DR   HOGENOM; CLU_115512_2_2_1; -.
DR   InParanoid; Q9UBF6; -.
DR   OMA; RQNNRCP; -.
DR   OrthoDB; 1587140at2759; -.
DR   PhylomeDB; Q9UBF6; -.
DR   TreeFam; TF351049; -.
DR   PathwayCommons; Q9UBF6; -.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-9705462; Inactivation of CSF3 (G-CSF) signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q9UBF6; -.
DR   SIGNOR; Q9UBF6; -.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 9616; 46 hits in 1131 CRISPR screens.
DR   ChiTaRS; RNF7; human.
DR   EvolutionaryTrace; Q9UBF6; -.
DR   GeneWiki; RNF7; -.
DR   GenomeRNAi; 9616; -.
DR   Pharos; Q9UBF6; Tbio.
DR   PRO; PR:Q9UBF6; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9UBF6; protein.
DR   Bgee; ENSG00000114125; Expressed in left adrenal gland and 195 other tissues.
DR   ExpressionAtlas; Q9UBF6; baseline and differential.
DR   Genevisible; Q9UBF6; HS.
DR   GO; GO:0031466; C:Cul5-RING ubiquitin ligase complex; IDA:MGI.
DR   GO; GO:0031461; C:cullin-RING ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005507; F:copper ion binding; TAS:ProtInc.
DR   GO; GO:0097602; F:cullin family protein binding; IDA:MGI.
DR   GO; GO:0061663; F:NEDD8 ligase activity; IDA:UniProtKB.
DR   GO; GO:0019788; F:NEDD8 transferase activity; TAS:Reactome.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; TAS:ProtInc.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0045116; P:protein neddylation; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.
DR   GO; GO:0051775; P:response to redox state; TAS:ProtInc.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR024766; Znf_RING_H2.
DR   Pfam; PF12678; zf-rbx1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cytoplasm; Metal-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   CHAIN           2..113
FT                   /note="RING-box protein 2"
FT                   /id="PRO_0000056023"
FT   ZN_FING         61..103
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          1..26
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         50
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         53
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         61
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250"
FT   BINDING         64
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250"
FT   BINDING         73
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250"
FT   BINDING         80
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         82
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         85
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         87
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250"
FT   BINDING         88
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         99
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         102
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   MOD_RES         10
FT                   /note="Phosphothreonine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:12748192"
FT   VAR_SEQ         57..113
FT                   /note="VMDACLRCQAENKQEDCVVVWGECNHSFHNCCMSLWVKQNNRCPLCQQDWVV
FT                   QRIGK -> MPVLDVKLKTNKRTVLWSGENVIIPSTTAACPCG (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_041444"
FT   VAR_SEQ         59..74
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_044525"
FT   VAR_SEQ         60..113
FT                   /note="ACLRCQAENKQEDCVVVWGECNHSFHNCCMSLWVKQNNRCPLCQQDWVVQRI
FT                   GK -> EGIGVRNWSEALNLINASEMGFDCRSGSTALAVPSVSLASHQPCLDDHR (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11506706,
FT                   ECO:0000303|PubMed:14702039"
FT                   /id="VSP_008449"
FT   CONFLICT        23
FT                   /note="K -> T (in Ref. 2; AAD30147)"
FT                   /evidence="ECO:0000305"
FT   STRAND          30..36
FT                   /evidence="ECO:0007829|PDB:7ONI"
FT   STRAND          39..43
FT                   /evidence="ECO:0007829|PDB:7ONI"
FT   STRAND          51..53
FT                   /evidence="ECO:0007829|PDB:7ONI"
FT   HELIX           62..67
FT                   /evidence="ECO:0007829|PDB:7ONI"
FT   TURN            70..72
FT                   /evidence="ECO:0007829|PDB:2ECL"
FT   STRAND          75..78
FT                   /evidence="ECO:0007829|PDB:7ONI"
FT   STRAND          83..85
FT                   /evidence="ECO:0007829|PDB:2ECL"
FT   HELIX           86..95
FT                   /evidence="ECO:0007829|PDB:7ONI"
FT   STRAND          100..102
FT                   /evidence="ECO:0007829|PDB:7ONI"
FT   STRAND          108..111
FT                   /evidence="ECO:0007829|PDB:7ONI"
SQ   SEQUENCE   113 AA;  12683 MW;  CE1E6CAC940C8257 CRC64;
     MADVEDGEET CALASHSGSS GSKSGGDKMF SLKKWNAVAM WSWDVECDTC AICRVQVMDA
     CLRCQAENKQ EDCVVVWGEC NHSFHNCCMS LWVKQNNRCP LCQQDWVVQR IGK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024